Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats
Open Access
- 31 July 2005
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 43 (1) , 98-103
- https://doi.org/10.1016/j.jhep.2005.02.022
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase II Study of the Flk-1 Tyrosine Kinase Inhibitor SU5416 in Advanced MelanomaClinical Cancer Research, 2004
- A Randomized Phase II Trial of the Antiangiogenic Agent SU5416 in Hormone-Refractory Prostate CancerClinical Cancer Research, 2004
- Vascular endothelial growth factor increases heme oxygenase‐1 protein expression in the chick embryo chorioallantoic membraneBritish Journal of Pharmacology, 2003
- Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal AntibodyToxicologic Pathology, 1999
- Mechanisms of angiogenesisNature, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: Influence in nitric oxide biosynthesisGastroenterology, 1996
- Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive ratsGastroenterology, 1995
- Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligationHepatology, 1993
- PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene SuperfamilyScience, 1990